BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/27/2024 11:58:45 AM | Browse: 641 | Download: 1639
Publication Name World Journal of Hepatology
Manuscript ID 90153
Country Japan
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report
Manuscript Source Unsolicited Manuscript
All Author List Yoshiki Morihisa, Hobyung Chung, Shuichiro Towatari, Daisuke Yamashita and Tetsuro Inokuma
ORCID
Author(s) ORCID Number
Yoshiki Morihisa http://orcid.org/0000-0002-8636-2488
Hobyung Chung http://orcid.org/0000-0003-1112-6533
Funding Agency and Grant Number
Corresponding Author Hobyung Chung, MD, PhD, Doctor, Doctor, Department of Gastroenterology and Hepatology, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminami-machi, Chuo-ku, Kobe 650-0047, Hyogo, Japan. teihiroshi@gmail.com
Key Words Liver; Hepatitis C virus; Autoimmune hepatitis; Primary sclerosing cholangitis; Immune system; Case report
Core Tip Direct-acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection are widely used as a safe and effective treatment intervention. Chronic HCV infection alters the innate and adaptive immune responses, both functionally and phenotypically. Rapid viral clearance following DAAs treatment restores adaptive immune function. Herein, we report a rare case of autoimmune hepatitis and primary sclerosing cholangitis that developed after DAAs treatment for HCV. The potential risk of developing autoimmune liver diseases after DAAs treatment owing to the restoration of host immunity following rapid viral clearance should be considered.
Publish Date 2024-02-27 11:58
Citation Morihisa Y, Chung H, Towatari S, Yamashita D, Inokuma T. Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report. World J Hepatol 2024; 16(2): 286-293
URL https://www.wjgnet.com/1948-5182/full/v16/i2/286.htm
DOI https://dx.doi.org/10.4254/wjh.v16.i2.286
Full Article (PDF) WJH-16-286-with-cover.pdf
Full Article (Word) WJH-16-286.docx